Oncogenic osteomalacia: Muscular weakness and multiple fractures

Neurology

Volumn 67, Issue 2, 2006, Pages 364-365

  Ladha, Shafeeq S ^a   Whitaker, Michael D ^a   Bosch, E Peter ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE TUMOR; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; ELECTRODIAGNOSIS; FRACTURE; HUMAN; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NEUROMUSCULAR FUNCTION; OSTEOMALACIA; PHYSIOTHERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; MULTIPLE TRAUMA;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; MULTIPLE TRAUMA; MUSCLE WEAKNESS; OSTEOMALACIA;

EID: 33747077223     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000225057.56863.33     Document Type: Article

References (7)

1. Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporosis Int 2002;13:187-194.
2. Irani PF. Electromyography in nutritional osteomalacic myopathy. J Neurol Neurosurg Psychiatry 1976;39:686-693.
3. Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia- associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 2004;28:1-30.
4. Carpenter TO. Oncogenic osteomalacia - a complex dance of factors. N Engl J Med 2003;348:1705-1708.
5. Jonsson KB, Zahradnik BS, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and x-linked hypophosphatemia. N Engl J Med 2003;348:1656-1663.
6. Sundaram M, McCarthy EF. Oncogenic osteomalacia. Skeletal Radiol 2000;29:117-124.
7. Subramanian R, Khardori R. Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment. Medicine 2000;79:1-8.